Cite Filings / TARS / 0001415889-25-021710

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Tarsus Pharmaceuticals, Inc. Filed 2025-08-14 Acc 0001415889-25-021710

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-13 4 President/CEO and Board Chair sold 6,000 shares at $50.00 ($300,000)
2025-08-11 144 Sale of Securities
2025-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…